Muscarinic cholinergic receptors in murine lymphocytes: demonstration by direct binding.
Melita A. Gordon, John Cohen, Irwin B. Wilson
Abstract
Melita A. Gordon, John Cohen, Irwin B. Wilson
Abstract
Using [3H]quinuclidinyl benzilate as a specific cholinergic muscarinic ligand, it has been demonstrated that lymphocytes have muscarinic binding sites. There are approximately 200 sites per cell and the dissociation constant for quinuclidinyl benzilate is approximately 1 X 10(-9) M. Quinuclidinyl benzilate receptor binding is blocked by atropine and oxotremorine.
OpenAlex reports 73 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Using [3H]quinuclidinyl benzilate as a specific cholinergic muscarinic ligand, it has been demonstrated that lymphocytes have muscarinic binding sites. There are approximately 200 sites per cell and the dissociation constant for quinuclidinyl benzilate is approximately 1 X 10(-9) M. Quinuclidinyl benzilate receptor binding is blocked by atropine and oxotremorine.
Key concepts: Quinuclidinyl Benzilate, Muscarinic acetylcholine receptor, Oxotremorine, Muscarinic acetylcholine receptor M4, Acetylcholine receptor, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M1, Atropine